메뉴 건너뛰기




Volumn 11, Issue 4, 2015, Pages 489-500

Recent advances in the understanding of immune-mediated nephrotic syndrome: Diagnostic and prognostic implications

Author keywords

amyloidosis; diagnostics; focal segmental glomerulosclerosis; IgA nephropathy; membranoproliferative glomerulonephritis; membranous nephropathy; minimal change disease; nephrotic syndrome; prognostics

Indexed keywords

AMYLOIDOSIS; AUTOIMMUNITY; DIAGNOSTIC PROCEDURE; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PROGNOSIS; PROTEINURIA; REVIEW; AMYLOID NEUROPATHIES; ANIMAL; BIOPSY; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY;

EID: 84925013136     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2015.1024659     Document Type: Review
Times cited : (3)

References (103)
  • 1
    • 4344685290 scopus 로고    scopus 로고
    • Signs and symptoms of thin basement membrane nephropathy: A prospective regional study on primary glomerular disease-the limburg renal registry
    • van Paassen P, van Breda Vriesman PJ, van Rie H, et al. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int 2004;66(3):909-13
    • (2004) Kidney Int , vol.66 , Issue.3 , pp. 909-913
    • Van Paassen, P.1    Van Breda Vriesman, P.J.2    Van Rie, H.3
  • 2
    • 23944452434 scopus 로고    scopus 로고
    • Management of membranous nephropathy: When and what for treatment
    • Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005;16(5):1188-94
    • (2005) J Am Soc Nephrol , vol.16 , Issue.5 , pp. 1188-1194
    • Cattran, D.1
  • 3
    • 0018133117 scopus 로고
    • Experimental glomerulonephritis in the isolated perfused rat kidney
    • Couser WG, Steinmuller DR, Stilmant MM, et al. Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 1978;62(6): 1275-87
    • (1978) J Clin Invest , vol.62 , Issue.6 , pp. 1275-1287
    • Couser, W.G.1    Steinmuller, D.R.2    Stilmant, M.M.3
  • 4
    • 0018825265 scopus 로고
    • In situ immune complex formation and glomerular injury
    • Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int 1980;17(1):1-13
    • (1980) Kidney Int , vol.17 , Issue.1 , pp. 1-13
    • Couser, W.G.1    Salant, D.J.2
  • 5
    • 0032920291 scopus 로고    scopus 로고
    • Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions
    • Topham PS, Haydar SA, Kuphal R, et al. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 1999;55(5):1763-75
    • (1999) Kidney Int , vol.55 , Issue.5 , pp. 1763-1775
    • Topham, P.S.1    Haydar, S.A.2    Kuphal, R.3
  • 6
    • 0344708488 scopus 로고    scopus 로고
    • Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy
    • Saran AM, Yuan H, Takeuchi E, et al. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy. Kidney Int 2003;64(6):2072-8
    • (2003) Kidney Int , vol.64 , Issue.6 , pp. 2072-2078
    • Saran, A.M.1    Yuan, H.2    Takeuchi, E.3
  • 7
    • 67649658244 scopus 로고    scopus 로고
    • M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy
    • Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361(1): 11-21
    • (2009) N Engl J Med , vol.361 , Issue.1 , pp. 11-21
    • Beck, L.H.1    Bonegio, R.G.2    Lambeau, G.3
  • 8
    • 79951827439 scopus 로고    scopus 로고
    • Risk hla-dqa1 and pla(2) r1 alleles in idiopathic membranous nephropathy
    • Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2) R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364(7): 616-26
    • (2011) N Engl J Med , vol.364 , Issue.7 , pp. 616-626
    • Stanescu, H.C.1    Arcos-Burgos, M.2    Medlar, A.3
  • 9
    • 84923919539 scopus 로고    scopus 로고
    • Identification of the immunodominant epitope region in phospholipase a2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy
    • Kao L, Lam V, Waldman M, et al. Identification of the immunodominant epitope region in phospholipase a2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol 2015;26(2):291-301
    • (2015) J Am Soc Nephrol , vol.26 , Issue.2 , pp. 291-301
    • Kao, L.1    Lam, V.2    Waldman, M.3
  • 10
    • 84875702300 scopus 로고    scopus 로고
    • Phospholipase a2 receptor (pla2r1) sequence variants in idiopathic membranous nephropathy
    • Coenen MJ, Hofstra JM, Debiec H, et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol 2013; 24(4):677-83
    • (2013) J Am Soc Nephrol , vol.24 , Issue.4 , pp. 677-683
    • Coenen, M.J.1    Hofstra, J.M.2    Debiec, H.3
  • 11
    • 84881117530 scopus 로고    scopus 로고
    • Interaction between pla2r1 and hla-dqa1 variants associates with anti-pla2r antibodies and membranous nephropathy
    • Lv J, Hou W, Zhou X, et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 2013;24(8):1323-9
    • (2013) J Am Soc Nephrol , vol.24 , Issue.8 , pp. 1323-1329
    • Lv, J.1    Hou, W.2    Zhou, X.3
  • 12
    • 79961085790 scopus 로고    scopus 로고
    • An immunofluorescence test for phospholipase- A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis
    • Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase- A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011;26(8):2526-32
    • (2011) Nephrol Dial Transplant , vol.26 , Issue.8 , pp. 2526-2532
    • Hoxha, E.1    Harendza, S.2    Zahner, G.3
  • 13
    • 84876441600 scopus 로고    scopus 로고
    • Development of a standardized elisa for the determination of autoantibodies against human m-type phospholipase a2 receptor in primary membranous nephropathy
    • Dahnrich C, Komorowski L, Probst C, et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 2013;421:213-18
    • (2013) Clin Chim Acta , vol.421 , pp. 213-218
    • Dahnrich, C.1    Komorowski, L.2    Probst, C.3
  • 14
    • 84904571214 scopus 로고    scopus 로고
    • Evaluation of anti-pla2r1 as measured by a novel elisa in patients with idiopathic membranous nephropathy: A cohort study
    • Timmermans SAMEG, Damoiseaux JG, Heerings-Rewinkel PT, et al. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol 2014;142(1):29-34
    • (2014) Am J Clin Pathol , vol.142 , Issue.1 , pp. 29-34
    • Timmermans, S.A.M.E.G.1    Damoiseaux, J.G.2    Heerings-Rewinkel, P.T.3
  • 15
    • 79951819917 scopus 로고    scopus 로고
    • PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy
    • Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011;364(7):689-90
    • (2011) N Engl J Med , vol.364 , Issue.7 , pp. 689-690
    • Debiec, H.1    Ronco, P.2
  • 16
    • 84884524462 scopus 로고    scopus 로고
    • Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
    • Svobodova B, Honsova E, Ronco P, et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 2013;28(7):1839-44
    • (2013) Nephrol Dial Transplant , vol.28 , Issue.7 , pp. 1839-1844
    • Svobodova, B.1    Honsova, E.2    Ronco, P.3
  • 17
    • 79957745793 scopus 로고    scopus 로고
    • Anti-phospholipase A2 receptor antibody in membranous nephropathy
    • Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011;22(6):1137-43
    • (2011) J Am Soc Nephrol , vol.22 , Issue.6 , pp. 1137-1143
    • Qin, W.1    Beck, L.H.2    Zeng, C.3
  • 18
    • 84877085738 scopus 로고    scopus 로고
    • Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies
    • Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 2013;26(5):709-15
    • (2013) Mod Pathol , vol.26 , Issue.5 , pp. 709-715
    • Larsen, C.P.1    Messias, N.C.2    Silva, F.G.3
  • 19
    • 84866422732 scopus 로고    scopus 로고
    • Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy
    • Hoxha E, Kneissler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012;82(7):797-804
    • (2012) Kidney Int , vol.82 , Issue.7 , pp. 797-804
    • Hoxha, E.1    Kneissler, U.2    Stege, G.3
  • 20
    • 84866119996 scopus 로고    scopus 로고
    • Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy
    • Murtas C, Bruschi M, Candiano G, et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 2012; 7(9):1394-400
    • (2012) Clin J Am Soc Nephrol , vol.7 , Issue.9 , pp. 1394-1400
    • Murtas, C.1    Bruschi, M.2    Candiano, G.3
  • 21
    • 84918548245 scopus 로고    scopus 로고
    • Thrombospondin type-1 domain-containing 7a in idiopathic membranous nephropathy
    • Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7a in idiopathic membranous nephropathy. N Engl J Med 2014;371(24):2277-87
    • (2014) N Engl J Med , vol.371 , Issue.24 , pp. 2277-2287
    • Tomas, N.M.1    Beck, L.H.2    Meyer-Schwesinger, C.3
  • 22
    • 0018397339 scopus 로고
    • Long-term prognosis of idiopathic membranous glomerulonephritis study of 116 untreated patients
    • Noel LH, Zanetti M, Droz D, et al. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 1979; 66(1):82-90
    • (1979) Am J Med , vol.66 , Issue.1 , pp. 82-90
    • Noel, L.H.1    Zanetti, M.2    Droz, D.3
  • 23
    • 83155182239 scopus 로고    scopus 로고
    • Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy
    • van Den Brand JA, Hofstra JM, Wetzels JF. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6(12):2846-53
    • (2011) Clin J Am Soc Nephrol , vol.6 , Issue.12 , pp. 2846-2853
    • Van Den Brand, J.A.1    Hofstra, J.M.2    Wetzels, J.F.3
  • 24
    • 0028785260 scopus 로고
    • A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
    • Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48(5):1600-4
    • (1995) Kidney Int , vol.48 , Issue.5 , pp. 1600-1604
    • Ponticelli, C.1    Zucchelli, P.2    Passerini, P.3
  • 25
    • 34249894713 scopus 로고    scopus 로고
    • A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy
    • Jha V, Ganguli A, Saha TK, et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18(6):1899-904
    • (2007) J Am Soc Nephrol , vol.18 , Issue.6 , pp. 1899-1904
    • Jha, V.1    Ganguli, A.2    Saha, T.K.3
  • 26
    • 85096618679 scopus 로고    scopus 로고
    • Chapter 7: Idiopathic membranous nephropathy
    • Kidney Disease improving Global Outcomes (KDIGO) Glomerulonephritis Work Group
    • Kidney Disease: improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Chapter 7: idiopathic membranous nephropathy. Kidney Int Suppl 2012;2(2):186-97
    • (2012) Kidney Int Suppl , vol.2 , Issue.2 , pp. 186-197
  • 27
    • 79958186439 scopus 로고    scopus 로고
    • Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy
    • Hofstra JM, Beck LH Jr, Beck DM, et al. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011;6(6):1286-91
    • (2011) Clin J Am Soc Nephrol , vol.6 , Issue.6 , pp. 1286-1291
    • Hofstra, J.M.1    Beck, L.H.2    Beck, D.M.3
  • 28
    • 84877023060 scopus 로고    scopus 로고
    • Anti-pla2r antibodies measured by elisa predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
    • Kanigicherla D, Gummadova J, McKenzie EA, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 2013;83(5):940-8
    • (2013) Kidney Int , vol.83 , Issue.5 , pp. 940-948
    • Kanigicherla, D.1    Gummadova, J.2    McKenzie, E.A.3
  • 29
    • 84867153044 scopus 로고    scopus 로고
    • Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy
    • Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23(10):1735-43
    • (2012) J Am Soc Nephrol , vol.23 , Issue.10 , pp. 1735-1743
    • Hofstra, J.M.1    Debiec, H.2    Short, C.D.3
  • 30
    • 84923930941 scopus 로고    scopus 로고
    • M-type phospholipase a2 receptor autoantibodies and renal function in patients with primary membranous nephropathy
    • Hoxha E, Harendza S, Pinnschmidt H, et al. M-type phospholipase a2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol 2014; 9(11):1883-90
    • (2014) Clin J Am Soc Nephrol , vol.9 , Issue.11 , pp. 1883-1890
    • Hoxha, E.1    Harendza, S.2    Pinnschmidt, H.3
  • 31
    • 79960948754 scopus 로고    scopus 로고
    • Rituximab-induced depletion of anti-pla2r autoantibodies predicts response in membranous nephropathy
    • Beck LH Jr, Fervenza FC, Beck DM, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011;22(8):1543-50
    • (2011) J Am Soc Nephrol , vol.22 , Issue.8 , pp. 1543-1550
    • Beck, L.H.1    Fervenza, F.C.2    Beck, D.M.3
  • 32
    • 84906088212 scopus 로고    scopus 로고
    • Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy
    • Hoxha E, Thiele I, Zahner G, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014;25(6):1357-66
    • (2014) J Am Soc Nephrol , vol.25 , Issue.6 , pp. 1357-1366
    • Hoxha, E.1    Thiele, I.2    Zahner, G.3
  • 33
    • 84921798402 scopus 로고    scopus 로고
    • Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy
    • Bech AP, Hofstra JM, Brenchley PE, et al. Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2014;9(8):1386-92
    • (2014) Clin J Am Soc Nephrol , vol.9 , Issue.8 , pp. 1386-1392
    • Bech, A.P.1    Hofstra, J.M.2    Brenchley, P.E.3
  • 34
    • 84874401903 scopus 로고    scopus 로고
    • Immunosuppression for progressive membranous nephropathy: A UK randomised controlled trial
    • Howman A, Chapman TL, Langdon MM, et al. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet 2013; 381(9868):744-51
    • (2013) Lancet , vol.381 , Issue.9868 , pp. 744-751
    • Howman, A.1    Chapman, T.L.2    Langdon, M.M.3
  • 35
    • 84864833114 scopus 로고    scopus 로고
    • Rituximab in idiopathic membranous nephropathy
    • Ruggenenti P, Cravedi P, Chianca A, et al. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23(8):1416-25
    • (2012) J Am Soc Nephrol , vol.23 , Issue.8 , pp. 1416-1425
    • Ruggenenti, P.1    Cravedi, P.2    Chianca, A.3
  • 36
    • 84899943190 scopus 로고    scopus 로고
    • Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing
    • Brown EJ, Pollak MR, Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int 2014;85(5):1030-8
    • (2014) Kidney Int , vol.85 , Issue.5 , pp. 1030-1038
    • Brown, E.J.1    Pollak, M.R.2    Barua, M.3
  • 37
    • 85096381157 scopus 로고    scopus 로고
    • Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults
    • Kidney Disease improving Glonal Outcomes (KDIGO) Glomerulonephritis Work Group
    • Kidney Disease: improving Glonal Outcomes (KDIGO) Glomerulonephritis Work Group. Chapter 6: idiopathic focal segmental glomerulosclerosis in adults. Kidney Int Suppl 2012;2(2):181-5
    • (2012) Kidney Int Suppl , vol.2 , Issue.2 , pp. 181-185
  • 38
    • 13344285352 scopus 로고    scopus 로고
    • Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
    • Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334(14):878-83
    • (1996) N Engl J Med , vol.334 , Issue.14 , pp. 878-883
    • Savin, V.J.1    Sharma, R.2    Sharma, M.3
  • 39
    • 0033052191 scopus 로고    scopus 로고
    • The FSGS factor: Enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma
    • Sharma M, Sharma R, McCarthy ET, Savin VJ. The FSGS factor: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999;10(3):552-61
    • (1999) J Am Soc Nephrol , vol.10 , Issue.3 , pp. 552-561
    • Sharma, M.1    Sharma, R.2    McCarthy, E.T.3    Savin, V.J.4
  • 40
    • 0035253559 scopus 로고    scopus 로고
    • Transmission of glomerular permeability factor from a mother to her child
    • Kemper MJ, Wolf G, Müller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 2001;344(5):386-7
    • (2001) N Engl J Med , vol.344 , Issue.5 , pp. 386-387
    • Kemper, M.J.1    Wolf, G.2    Müller-Wiefel, D.E.3
  • 41
    • 84872354111 scopus 로고    scopus 로고
    • Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (supar) from a mother to child
    • Kemper MJ, Wei C, Reiser J. Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis 2013;61(2):352
    • (2013) Am J Kidney Dis , vol.61 , Issue.2 , pp. 352
    • Kemper, M.J.1    Wei, C.2    Reiser, J.3
  • 42
    • 79961132981 scopus 로고    scopus 로고
    • Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
    • Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011;17(8):952-60
    • (2011) Nat Med , vol.17 , Issue.8 , pp. 952-960
    • Wei, C.1    El Hindi, S.2    Li, J.3
  • 43
    • 84870546490 scopus 로고    scopus 로고
    • Circulating suPAR in two cohorts of primary FSGS
    • Wei C, Trachtman H, Li J, et al. Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 2012; 23(12):2051-9
    • (2012) J Am Soc Nephrol , vol.23 , Issue.12 , pp. 2051-2059
    • Wei, C.1    Trachtman, H.2    Li, J.3
  • 44
    • 84895155571 scopus 로고    scopus 로고
    • The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
    • Meijers B, Maas RJ, Sprangers B, et al. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 2014;85(3): 636-40
    • (2014) Kidney Int , vol.85 , Issue.3 , pp. 636-640
    • Meijers, B.1    Maas, R.J.2    Sprangers, B.3
  • 45
    • 84881244297 scopus 로고    scopus 로고
    • Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic fsgs in children: A single-center report
    • Bock ME, Price HE, Gallon L, et al. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 2013;8(8):1304-11
    • (2013) Clin J Am Soc Nephrol , vol.8 , Issue.8 , pp. 1304-1311
    • Bock, M.E.1    Price, H.E.2    Gallon, L.3
  • 46
    • 34748843166 scopus 로고    scopus 로고
    • A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases
    • Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2007;2(3):529-42
    • (2007) Clin J Am Soc Nephrol , vol.2 , Issue.3 , pp. 529-542
    • Barisoni, L.1    Schnaper, H.W.2    Kopp, J.B.3
  • 47
    • 59949099339 scopus 로고    scopus 로고
    • Urinary CD80 excretion increases in idiopathic minimal-change disease
    • Garin EH, Diaz LN, Mu W, et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 2009;20(2):260-6
    • (2009) J Am Soc Nephrol , vol.20 , Issue.2 , pp. 260-266
    • Garin, E.H.1    Diaz, L.N.2    Mu, W.3
  • 48
    • 77954733049 scopus 로고    scopus 로고
    • Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis
    • Garin EH, Mu W, Arthur JM, et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010;78(3): 296-302
    • (2010) Kidney Int , vol.78 , Issue.3 , pp. 296-302
    • Garin, E.H.1    Mu, W.2    Arthur, J.M.3
  • 49
    • 34547815735 scopus 로고    scopus 로고
    • Podocyte protection by darbepoetin: Preservation of the cytoskeleton and nephrin expression
    • Eto N, Wada T, Inagi R, et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression. Kidney Int 2007;72(4):455-63
    • (2007) Kidney Int , vol.72 , Issue.4 , pp. 455-463
    • Eto, N.1    Wada, T.2    Inagi, R.3
  • 50
    • 84924964566 scopus 로고    scopus 로고
    • Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis
    • Garin EH, Reiser J, Cara-Fuentes G, et al. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis. Pediatr Nephrol 2015; 30(3):469-77
    • (2015) Pediatr Nephrol , vol.30 , Issue.3 , pp. 469-477
    • Garin, E.H.1    Reiser, J.2    Cara-Fuentes, G.3
  • 51
    • 84925000866 scopus 로고    scopus 로고
    • Misdiagnosing renal amyloidosis as minimal change disease
    • Sayed RH, Gilbertson JA, Hutt DF, et al. Misdiagnosing renal amyloidosis as minimal change disease. Nephrol Dial Transplant 2014;29(11):2120-6
    • (2014) Nephrol Dial Transplant , vol.29 , Issue.11 , pp. 2120-2126
    • Sayed, R.H.1    Gilbertson, J.A.2    Hutt, D.F.3
  • 52
    • 84883674592 scopus 로고    scopus 로고
    • Renal amyloidosis: Origin and clinicopathologic correlations of 474 recent cases
    • Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 2013;8(9):1515-23
    • (2013) Clin J Am Soc Nephrol , vol.8 , Issue.9 , pp. 1515-1523
    • Said, S.M.1    Sethi, S.2    Valeri, A.M.3
  • 53
    • 0028970456 scopus 로고
    • Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
    • Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32(1): 45-59
    • (1995) Semin Hematol , vol.32 , Issue.1 , pp. 45-59
    • Kyle, R.A.1    Gertz, M.A.2
  • 54
    • 84868157601 scopus 로고    scopus 로고
    • How i treat amyloidosis: The importance of accurate diagnosis and amyloid typing
    • Leung N, Nasr SH, Sethi S. How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing. Blood 2012; 120(16):3206-13
    • (2012) Blood , vol.120 , Issue.16 , pp. 3206-3213
    • Leung, N.1    Nasr, S.H.2    Sethi, S.3
  • 55
  • 56
    • 0029001438 scopus 로고
    • Galactosylation of n- and o-linked carbohydrate moieties of iga1 and igg in iga nephropathy
    • Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100(3):470-4
    • (1995) Clin Exp Immunol , vol.100 , Issue.3 , pp. 470-474
    • Allen, A.C.1    Harper, S.J.2    Feehally, J.3
  • 57
    • 67651006853 scopus 로고    scopus 로고
    • Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
    • Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009;119(6):1668-77
    • (2009) J Clin Invest , vol.119 , Issue.6 , pp. 1668-1677
    • Suzuki, H.1    Fan, R.2    Zhang, Z.3
  • 58
    • 34249099962 scopus 로고    scopus 로고
    • Iga nephropathy and henoch-schoenlein purpura nephritis: Aberrant glycosylation of iga1, formation of iga1-containing immune complexes, and activation of mesangial cells
    • Novak J, Moldoveanu Z, Renfrow MB, et al. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 2007;157:134-8
    • (2007) Contrib Nephrol , vol.157 , pp. 134-138
    • Novak, J.1    Moldoveanu, Z.2    Renfrow, M.B.3
  • 59
    • 84867164317 scopus 로고    scopus 로고
    • Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria
    • Gutierrez E, Zamora I, Ballarin JA, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 2012;23(10):1753-60
    • (2012) J Am Soc Nephrol , vol.23 , Issue.10 , pp. 1753-1760
    • Gutierrez, E.1    Zamora, I.2    Ballarin, J.A.3
  • 60
    • 0035870771 scopus 로고    scopus 로고
    • The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria
    • Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001; 110(6):434-7
    • (2001) Am J Med , vol.110 , Issue.6 , pp. 434-437
    • Szeto, C.C.1    Lai, F.M.2    To, K.F.3
  • 61
    • 46649106141 scopus 로고    scopus 로고
    • Clinical course and prognostic factors of clinical early IgA nephropathy
    • Shen P, He L, Huang D. Clinical course and prognostic factors of clinical early IgA nephropathy. Neth J Med 2008;66(6): 242-7
    • (2008) Neth J Med , vol.66 , Issue.6 , pp. 242-247
    • Shen, P.1    He, L.2    Huang, D.3
  • 63
    • 80051575524 scopus 로고    scopus 로고
    • Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy
    • Camilla R, Suzuki H, Dapra V, et al. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol 2011;6(8):1903-11
    • (2011) Clin J Am Soc Nephrol , vol.6 , Issue.8 , pp. 1903-1911
    • Camilla, R.1    Suzuki, H.2    Dapra, V.3
  • 64
    • 84866376076 scopus 로고    scopus 로고
    • The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
    • Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 2012; 82(7):790-6
    • (2012) Kidney Int , vol.82 , Issue.7 , pp. 790-796
    • Zhao, N.1    Hou, P.2    Lv, J.3
  • 65
    • 84865976351 scopus 로고    scopus 로고
    • Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy
    • Berthoux F, Suzuki H, Thibaudin L, et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 2012; 23(9):1579-87
    • (2012) J Am Soc Nephrol , vol.23 , Issue.9 , pp. 1579-1587
    • Berthoux, F.1    Suzuki, H.2    Thibaudin, L.3
  • 66
    • 84863576385 scopus 로고    scopus 로고
    • Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy
    • Liu LL, Jiang Y, Wang LN, et al. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy. Clin Exp Immunol 2012;169(2):148-55
    • (2012) Clin Exp Immunol , vol.169 , Issue.2 , pp. 148-155
    • Liu, L.L.1    Jiang, Y.2    Wang, L.N.3
  • 67
    • 33646924264 scopus 로고    scopus 로고
    • Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease
    • Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006;17(6):1724-34
    • (2006) J Am Soc Nephrol , vol.17 , Issue.6 , pp. 1724-1734
    • Roos, A.1    Rastaldi, M.P.2    Calvaresi, N.3
  • 68
    • 84883647615 scopus 로고    scopus 로고
    • Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy
    • Liu LL, Liu N, Chen Y, et al. Glomerular mannose-binding lectin deposition is a useful prognostic predictor in immunoglobulin A nephropathy. Clin Exp Immunol 2013;174(1):152-60
    • (2013) Clin Exp Immunol , vol.174 , Issue.1 , pp. 152-160
    • Liu, L.L.1    Liu, N.2    Chen, Y.3
  • 69
    • 84858668780 scopus 로고    scopus 로고
    • Membranoproliferative glomerulonephritis-a new look at an old entity
    • Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 2012;366(12):1119-31
    • (2012) N Engl J Med , vol.366 , Issue.12 , pp. 1119-1131
    • Sethi, S.1    Fervenza, F.C.2
  • 70
    • 0027393927 scopus 로고
    • Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
    • Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328(7):465-70
    • (1993) N Engl J Med , vol.328 , Issue.7 , pp. 465-470
    • Johnson, R.J.1    Gretch, D.R.2    Yamabe, H.3
  • 71
    • 77952300995 scopus 로고    scopus 로고
    • Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy
    • Sethi S, Zand L, Leung N, et al. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol 2010;5(5):770-82
    • (2010) Clin J Am Soc Nephrol , vol.5 , Issue.5 , pp. 770-782
    • Sethi, S.1    Zand, L.2    Leung, N.3
  • 72
    • 0347992788 scopus 로고    scopus 로고
    • Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
    • Nasr SH, Markowitz GS, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 2004;65(1): 85-96
    • (2004) Kidney Int , vol.65 , Issue.1 , pp. 85-96
    • Nasr, S.H.1    Markowitz, G.S.2    Stokes, M.B.3
  • 73
    • 84869779556 scopus 로고    scopus 로고
    • Monoclonal gammopathy of renal significance: When MGUS is no longer undetermined or insignificant
    • Leung N, Bridoux F, Hutchison CA, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 2012; 120(22):4292-5
    • (2012) Blood , vol.120 , Issue.22 , pp. 4292-4295
    • Leung, N.1    Bridoux, F.2    Hutchison, C.A.3
  • 74
    • 69849086679 scopus 로고    scopus 로고
    • Proliferative glomerulonephritis with monoclonal IgG deposits
    • Nasr SH, Satoskar A, Markowitz GS, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009;20(9):2055-64
    • (2009) J Am Soc Nephrol , vol.20 , Issue.9 , pp. 2055-2064
    • Nasr, S.H.1    Satoskar, A.2    Markowitz, G.S.3
  • 75
    • 84896701896 scopus 로고    scopus 로고
    • Membranoproliferative glomerulonephritis: The times they are a-changin
    • Cohen Tervaert JW. Membranoproliferative glomerulonephritis: the times they are a-changin. Clin Exp Nephrol 2014;18(1): 1-3
    • (2014) Clin Exp Nephrol , vol.18 , Issue.1 , pp. 1-3
    • Cohen Tervaert, J.W.1
  • 76
    • 84896695997 scopus 로고    scopus 로고
    • Membranoproliferative glomerulonephritis and circulating cryoglobulins
    • Hiramatsu R, Hoshino J, Suwabe T, et al. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol 2014;18(1):88-94
    • (2014) Clin Exp Nephrol , vol.18 , Issue.1 , pp. 88-94
    • Hiramatsu, R.1    Hoshino, J.2    Suwabe, T.3
  • 77
    • 3042767356 scopus 로고    scopus 로고
    • Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
    • Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33(6):355-74
    • (2004) Semin Arthritis Rheum , vol.33 , Issue.6 , pp. 355-374
    • Ferri, C.1    Sebastiani, M.2    Giuggioli, D.3
  • 78
    • 34648817584 scopus 로고    scopus 로고
    • Type ii cryoglobulinemia is not associated with hepatitis c infection: The dutch experience
    • Tervaert JW, Van Paassen P, Damoiseaux J. Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience. Ann N Y Acad Sci 2007;1107: 251-8
    • (2007) Ann N y Acad Sci , vol.1107 , pp. 251-258
    • Tervaert, J.W.1    Van Paassen, P.2    Damoiseaux, J.3
  • 79
    • 38749148451 scopus 로고    scopus 로고
    • A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins
    • Vermeersch P, Gijbels K, Marien G, et al. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem 2008;54(1):39-43
    • (2008) Clin Chem , vol.54 , Issue.1 , pp. 39-43
    • Vermeersch, P.1    Gijbels, K.2    Marien, G.3
  • 80
    • 84896313743 scopus 로고    scopus 로고
    • Diagnostics and treatment of cryoglobulinaemia: It takes two to tango
    • Damoiseaux J, Cohen Tervaert JW. Diagnostics and treatment of cryoglobulinaemia: it takes two to tango. Clin Rev Allergy Immunol 2014;47(3): 299-310
    • (2014) Clin Rev Allergy Immunol , vol.47 , Issue.3 , pp. 299-310
    • Damoiseaux, J.1    Cohen Tervaert, J.W.2
  • 81
    • 84871193435 scopus 로고    scopus 로고
    • Idiopathic membranoproliferative glomerulonephritis: Does it exist?
    • Fervenza FC, Sethi S, Glassock RJ. Idiopathic membranoproliferative glomerulonephritis: does it exist?. Nephrol Dial Transplant 2012;27(12):4288-94
    • (2012) Nephrol Dial Transplant , vol.27 , Issue.12 , pp. 4288-4294
    • Fervenza, F.C.1    Sethi, S.2    Glassock, R.J.3
  • 82
    • 0035810399 scopus 로고    scopus 로고
    • Complement. First of two parts
    • Walport MJ. Complement. First of two parts. N Engl J Med 2001;344(14):1058-66
    • (2001) N Engl J Med , vol.344 , Issue.14 , pp. 1058-1066
    • Walport, M.J.1
  • 83
    • 0035849176 scopus 로고    scopus 로고
    • Complement. Second of two parts
    • Walport MJ. Complement. Second of two parts. N Engl J Med 2001;344(15):1140-4
    • (2001) N Engl J Med , vol.344 , Issue.15 , pp. 1140-1144
    • Walport, M.J.1
  • 84
    • 84864554927 scopus 로고    scopus 로고
    • Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
    • Servais A, Noel LH, Roumenina LT, et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 2012; 82(4):454-64
    • (2012) Kidney Int , vol.82 , Issue.4 , pp. 454-464
    • Servais, A.1    Noel, L.H.2    Roumenina, L.T.3
  • 85
    • 77957827919 scopus 로고    scopus 로고
    • Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation
    • Martinez-Barricarte R, Heurich M, Valdes-Canedo F, et al. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest 2010;120(10): 3702-12
    • (2010) J Clin Invest , vol.120 , Issue.10 , pp. 3702-3712
    • Martinez-Barricarte, R.1    Heurich, M.2    Valdes-Canedo, F.3
  • 86
    • 77956394517 scopus 로고    scopus 로고
    • Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis
    • Gale DP, De Jorge EG, Cook HT, et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010;376(9743):794-801
    • (2010) Lancet , vol.376 , Issue.9743 , pp. 794-801
    • Gale, D.P.1    De Jorge, E.G.2    Cook, H.T.3
  • 87
    • 84868585648 scopus 로고    scopus 로고
    • Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
    • Paixao-Cavalcante D, Lopez-Trascasa M, Skattum L, et al. Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 2012;82(10): 1084-92
    • (2012) Kidney Int , vol.82 , Issue.10 , pp. 1084-1092
    • Paixao-Cavalcante, D.1    Lopez-Trascasa, M.2    Skattum, L.3
  • 88
    • 84863115476 scopus 로고    scopus 로고
    • Causes of alternative pathway dysregulation in dense deposit disease
    • Zhang Y, Meyer NC, Wang K, et al. Causes of alternative pathway dysregulation in dense deposit disease. Clin J Am Soc Nephrol 2012;7(2):265-74
    • (2012) Clin J Am Soc Nephrol , vol.7 , Issue.2 , pp. 265-274
    • Zhang, Y.1    Meyer, N.C.2    Wang, K.3
  • 89
    • 80052573272 scopus 로고    scopus 로고
    • Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy a fortuitous association?
    • Bridoux F, Desport E, Fremeaux-Bacchi V, et al. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?. Clin J Am Soc Nephrol 2011;6(9):2165-74
    • (2011) Clin J Am Soc Nephrol , vol.6 , Issue.9 , pp. 2165-2174
    • Bridoux, F.1    Desport, E.2    Fremeaux-Bacchi, V.3
  • 90
    • 84888641200 scopus 로고    scopus 로고
    • C3 glomerulopathy: Consensus report
    • Pickering MC, DAgati VD, Nester CM, et al. C3 glomerulopathy: consensus report. Kidney Int 2013;84(6):1079-89
    • (2013) Kidney Int , vol.84 , Issue.6 , pp. 1079-1089
    • Pickering, M.C.1    Dagati, V.D.2    Nester, C.M.3
  • 91
    • 84906077328 scopus 로고    scopus 로고
    • Syndromes of thrombotic microangiopathy
    • George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 2014;371(7):654-66
    • (2014) N Engl J Med , vol.371 , Issue.7 , pp. 654-666
    • George, J.N.1    Nester, C.M.2
  • 92
    • 34250329129 scopus 로고    scopus 로고
    • Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
    • Pickering MC, De Jorge EG, Martinez-Barricarte R, et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 2007; 204(6):1249-56
    • (2007) J Exp Med , vol.204 , Issue.6 , pp. 1249-1256
    • Pickering, M.C.1    De Jorge, E.G.2    Martinez-Barricarte, R.3
  • 93
    • 84884308134 scopus 로고    scopus 로고
    • Estimating renal survival using the ANCA-associated GN classification
    • Hilhorst M, Wilde B, van Breda Vriesman P, et al. Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 2013; 24(9):1371-5
    • (2013) J Am Soc Nephrol , vol.24 , Issue.9 , pp. 1371-1375
    • Hilhorst, M.1    Wilde, B.2    Van Breda Vriesman, P.3
  • 94
    • 15144339407 scopus 로고    scopus 로고
    • Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis ec/bcr project for anca assay standardization
    • Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998;53(3):743-53
    • (1998) Kidney Int , vol.53 , Issue.3 , pp. 743-753
    • Hagen, E.C.1    Daha, M.R.2    Hermans, J.3
  • 95
    • 84871641115 scopus 로고    scopus 로고
    • Antineutrophil cytoplasmic autoantibodies: How are they detected and what is their use for diagnosis, classification and follow-up?
    • Cohen Tervaert JW, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?. Clin Rev Allergy Immunol 2012;43(3): 211-19
    • (2012) Clin Rev Allergy Immunol , vol.43 , Issue.3 , pp. 211-219
    • Cohen Tervaert, J.W.1    Damoiseaux, J.2
  • 96
    • 84923327980 scopus 로고    scopus 로고
    • ANCA as a predictor of relapse: Useful in patients with renal involvement but not in patients with nonrenal disease
    • Epub ahead of print
    • Kemna MJ, Damoiseaux J, Austen J, et al. ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. J Am Soc Nephrol 2014. [Epub ahead of print
    • (2014) J Am Soc Nephrol
    • Kemna, M.J.1    Damoiseaux, J.2    Austen, J.3
  • 97
    • 32544444877 scopus 로고    scopus 로고
    • Systemic lupus erythematosus in europe at the change of the millennium: Lessons from the euro- lupus project
    • Cervera R, Abarca-Costalago M, Abramovicz D, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the Euro- Lupus Project. Autoimmun Rev 2006;5(3): 180-6
    • (2006) Autoimmun Rev , vol.5 , Issue.3 , pp. 180-186
    • Cervera, R.1    Abarca-Costalago, M.2    Abramovicz, D.3
  • 98
    • 0942265440 scopus 로고    scopus 로고
    • The classification of glomerulonephritis in systemic lupus erythematosus revisited
    • Weening JJ, DAgati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15(2):241-50
    • (2004) J Am Soc Nephrol , vol.15 , Issue.2 , pp. 241-250
    • Weening, J.J.1    Dagati, V.D.2    Schwartz, M.M.3
  • 99
    • 0020644042 scopus 로고
    • Pathologic differentiation between lupus and nonlupus membranous glomerulopathy
    • Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983;24(3):377-85
    • (1983) Kidney Int , vol.24 , Issue.3 , pp. 377-385
    • Jennette, J.C.1    Iskandar, S.S.2    Dalldorf, F.G.3
  • 100
  • 101
    • 84912105289 scopus 로고    scopus 로고
    • Clinical immunology - Autoimmunity in the Netherlands
    • 2PB
    • Tervaert JW, Kallenberg CG. Clinical immunology - Autoimmunity in the Netherlands. Immunol Lett 2014;162(2PB): 134-40
    • (2014) Immunol Lett , vol.162 , pp. 134-140
    • Tervaert, J.W.1    Kallenberg, C.G.2
  • 102
    • 4944245001 scopus 로고    scopus 로고
    • Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes
    • Trouw LA, Groeneveld TW, Seelen MA, et al. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 2004;114(5):679-88
    • (2004) J Clin Invest , vol.114 , Issue.5 , pp. 679-688
    • Trouw, L.A.1    Groeneveld, T.W.2    Seelen, M.A.3
  • 103
    • 84865708432 scopus 로고    scopus 로고
    • Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis
    • Yang XW, Tan Y, Yu F, et al. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis. Nephrol Dial Transplant 2012;27(9):3552-9
    • (2012) Nephrol Dial Transplant , vol.27 , Issue.9 , pp. 3552-3559
    • Yang, X.W.1    Tan, Y.2    Yu, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.